IN DATA

Powered by 

Deals analysis

Rankings

Economic data

Macro-economic indicators

INSIDE THE DEAL

Imcyse closes €21.3m Series B funding round

Imcyse has secured funding to continue developing novel immunotherapies for severe autoimmune diseases

Deals Analysis

Year-on-year deals volume continues to decline

A breakdown of deals by region shows that year-on-year pharma industry deals have declined

Rankings

Who's leading in Europe in terms of market cap

Our pharma industry key list brings you the 15 leading biopharma companies in Europe by revenue

Deals analysis

Rankings

Economic data

Macro-economic indicators

02/24/2024 02:03:12
  • Home | Relinking the pharma supply chain
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Datwyler Company Insight
  • Datwyler
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • ILC Dover
  • Butterworth
  • Comment
  • New Chinese Breakthrough Therapy designation attracts foreign companies
  • Endometrial cancer patients expected to benefit from novel advancements
  • Regulatory and strategic complications of marketing an oncology drug in Asia
  • The biopharma revolution: navigating complexity
  • TRiBECA Knowledge
  • PerkinElmer
  • In Depth
  • What’s in a drug name?
  • Improving care for rare diseases in India
  • Focus on the patient, not the pill
  • Academic-industry collaboration
  • Rewriting the pharma supply chain for a post-pandemic world
  • Developing an oral Covid-19 vaccine
  • The Solubility Company - Company Insight
  • The Solubility company
  • In Data
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
06/01/2021 00:00:00